NDC product
ED BRON GP
NDC 0485-0208 · EDWARDS PHARMACEUTICALS, INC.
Key facts
| Product NDC | 0485-0208 |
|---|---|
| Proprietary name | ED BRON GP |
| Nonproprietary name | GUAIFENESIN and PHENYLEPHRINE |
| Substances | GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | EDWARDS PHARMACEUTICALS, INC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Jun 1, 2012 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: